Member Info for unvrkw

Oxo, go on the grimsby evening telegraph page and it highlights David Ross not getting the ofsted job, interesting, not sure whether people have also fed in their reservations which can of course influence decisions!!

Big update on the website in regards CD4. Available to buy and explained in full detail of how and what it does. Big change and obviously the proposed ramp up in activity that is due this financial year.

Many lost on the above flight, I note that people from omega intended to attend the event, so hopefully not one has been lost but irrespective of anything it's just a great trategy.

Massive amount on marketing and sales costs plus is the deals don't go through then we will spend the rest on the same, isn't 6500 metric tonnes of marble a lot to have sitting around? I have no idea how fast it goes but the recent deal was seen as significant and that is nothing compared to the stock. They need the Chinese deals signed that guarantee some volume.

Can be read in several ways that the quarry opposite ours has seen the performance since fox arrived and wishes to do business. We do now have over 6000 tonnes of stock and we need this quarry to stay variable and sales are slower in other sectors? Not sure and it doesn't highlight who gets the right to the share, states a 6% Premium on the price quoted which I assume is based against the spread as still very close. The quote from the CEO was that we had over 3000 years worth of marble, seems we have it all but not the right type?

It always seem the journey from beginning to the pot of gold goes on and on. There is never that clear site of end game, thanks very much and sp increase as we hope for often enough. Keep in here, will read and ask about the stock placing but suspect will be done and dusted pretty quickly.

Above today's price not 16 pence. I think these shares are already sold and investors lined up, private sps won't see them.

The reason for the cash seems very positive and the dilution in not crazy with the number of shares in circulation neither excessive. Whilst I would rather this not happen, are they struggling to sell marble bar the more exclusive which means this needs to be done, only a few months ago no funding was needed.

80 or 85% then Henderson can auto purchase all shares left without an issue. They may do this and there is obviously some confidence as we shall see.

Last year we got one in July early ish, maybe another due in the next week or so?

It already implies that CD4 is an integral product in this role out and an expected product. Commenting on the partnership, Andrew Shepherd, CEO of Omega said: "Current lab based static diagnostics tools are unable to meet growing patients' needs as countries step up their HIV treatment programmes in conjunction with the decentralisation of CD4 testing. CD4 product testing is being managed and decentralised, this is happening

We only get a certain percentage for the sivec however at this stage a sale of any type is positive and promotes the company. Realistically for 15 million euro next year we need quite a few regular announcements. It's described as being a pivotal year, hopefully the brokers comments are correct and £1.30 mark is possible. That would be mortgage resolved!

its a fraction i think of what is expected by next year but they are confirmed and demonstartes that people will obvioulsy buy. not sure how many, how often they will publish these types of orders as we need 10 million + euro deals to get some good momentum and profit. suspect now over the next few months we will see the updates and manufacturing ramps up with the factory being completed and margins for the business improved. sitting tight here, happy to wait 18 months.

Final results from Immunodiagnostic Systems (IDS) were broadly in line with expectations, as the company outlined a new five-year strategy to double revenues by increasing the installed base of its IDS-iSYS instruments and its menu of tests

the ceo has a record of realising great value, i think this sp should do well over the next year and the report is as bullish as it possibly can be without saying something it shouldnt. there is not only the CD4 test but other global tests now being worked upon and also entry into the HIV market which is worth billions. behind this the 40 test platform to challenge the no.1 in the world is not bad at all, good year ahead with announcements to come.

we all have a dislike for complete uncertainty and that is our challenge in being able to set our budgets for the current year in relation to both the timing and quantum of CD4 revenues. CD4 will, without doubt, be a successful product for the Group, but we would be foolish to believe that our crystal ball is better than yours in being able to forecast with certainty the decision outputs from the NGOs we are working with

All options are awarded under the Company's EMI Share Option Scheme. The options have a three year vesting period, have been awarded at an exercise price of 30.5p (closing mid-market price on 24 February 2014) and after they are fully vested, there is a performance criteria that they cannot be exercised until the share price is at 50p or higher.

not sure whether we will see an upswing before these come, or a trading update at the same time. i will buy a few more today and then next week also. this share is all about its products which i think will sell well and of course the longer term CD4. but when you build two factories to make the product whilst on field testing then you must be pretty clear its going to go ok. immune to economic times and hayfever etc are up this year, weather as been perfect for this, my wife can tell you!!

Expect 50 pence at least by year end, going to see some more confirmed sales soon and the quarrying continue to increase, no stopping this

Not a lot to report I guess over this next period as we await the pivotal change! Keep going, stick in there!